173 related articles for article (PubMed ID: 6988103)
1. Angiotensin II, plasma renin and sodium depletion as determinants of blood pressure response to saralasin in essential hypertension.
Thananopavarn C; Golub MS; Eggena P; Barrett JD; Sambhi MP
Circulation; 1980 May; 61(5):920-4. PubMed ID: 6988103
[TBL] [Abstract][Full Text] [Related]
2. Renin, sodium, and vasodepressor response to saralasin in renovascular and essential hypertension.
Marks LS; Maxwell MH; Kaufman JJ
Ann Intern Med; 1977 Aug; 87(2):176-82. PubMed ID: 889198
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin II blockade before and after marked sodium depletion in patients with hypertension.
Van Hoogdalem P; Donker AJ; Leenen FH
Clin Sci Mol Med; 1978 Jan; 54(1):75-83. PubMed ID: 620496
[TBL] [Abstract][Full Text] [Related]
4. [Saralasin in subjects with low renin arterial hypertension].
Frisina N; Buemi M; Lasco A; Macrí I; Ciraolo O; Nicita Mauro V; Costa G
Boll Soc Ital Biol Sper; 1980 Jul; 56(13):1367-73. PubMed ID: 7004464
[TBL] [Abstract][Full Text] [Related]
5. Diuretic therapy and response of essential hypertension to saralasin.
Anderson GH; Dalakos TG; Elias A; Tomycz N; Streeten DH
Ann Intern Med; 1977 Aug; 87(2):183-7. PubMed ID: 889199
[TBL] [Abstract][Full Text] [Related]
6. The effects of saralasin, an angiotensin II antagonist, on blood pressure and the renin-angiotensin-aldosterone system in normal and hypertensive subjects.
Brown JJ; Brown WC; Fraser R; Lever AF; Morton JJ; Robertson JI; Rosei EA; Trust PM
Aust N Z J Med; 1976 Aug; 6(3 Suppl):48-52. PubMed ID: 1071403
[TBL] [Abstract][Full Text] [Related]
7. Pressor response to 1-sar-8-ala-angiotensin II (saralasin) in hypertensive subjects.
Anderson GH; Streeten DH; Dalakos TG
Circ Res; 1977 Mar; 40(3):243-50. PubMed ID: 837471
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic and pharmacodynamic studies of infusions with [Sar 1, Val5, Ala8] angiotensin II (saralasin).
Gless KH; Bönner G; Gram N; Mann JF; Helber A; Ganten D
Klin Wochenschr; 1978; 56 Suppl 1():97-105. PubMed ID: 732257
[TBL] [Abstract][Full Text] [Related]
9. Pressor response to saralasin (1-sar-8-ala-angiotensin II) bolus injection in hypertensive patients.
Waks UA; Maxwell MH; Marks L; Zawada ET; Kaufman JJ
Circulation; 1978 Jun; 57(6):1165-70. PubMed ID: 639240
[TBL] [Abstract][Full Text] [Related]
10. Hypotensive effects of sodium volume depletion and 1-sar-8-ala-angiotensin II in relation to plasma renin in hypertensive patients.
Fagard R; Amery A; Lijnen P; Reybrouck T
Eur J Clin Pharmacol; 1977 Aug; 12(1):1-5. PubMed ID: 902672
[TBL] [Abstract][Full Text] [Related]
11. The immediate pressor effect of saralasin in man.
Carey RM; Vaughan ED; Ackerly JA; Peach MJ; Ayers CR
J Clin Endocrinol Metab; 1978 Jan; 46(1):36-43. PubMed ID: 752023
[TBL] [Abstract][Full Text] [Related]
12. Usefulness and limitations of saralasin, a partial competitive agonist of angioten II, for evaluating the renin and sodium factors in hypertensive patients.
Case DB; Wallace JM; Keim HJ; Sealey JE; Laragh JH
Am J Med; 1976 May; 60(6):825-36. PubMed ID: 1020762
[TBL] [Abstract][Full Text] [Related]
13. Relationship between the hypotensive and renin-stimulating actions of diuretic therapy in hypertensive patients.
Leonetti G; Terzoli L; Sala C; Bianchini C; Sernesi L; Zanchetti A
Clin Sci Mol Med Suppl; 1978 Dec; 4():307s-309s. PubMed ID: 282074
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin blockade: its clinical significance.
Streeten DH; Anderson GH; Dalakos TH
Am J Med; 1976 May; 60(6):817-24. PubMed ID: 1020761
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II blockade during combined thiazide-beta-adrenoreceptor-blocker treatment.
Ibsen H; Leth A; McNair A; Giese J
Clin Sci (Lond); 1979 Dec; 57 Suppl 5():123s-125s. PubMed ID: 396064
[TBL] [Abstract][Full Text] [Related]
16. Detection of renovascular hypertension with angiotensin II blockade.
Baer L; Parra-Carrilo JZ; Radichevich I; Williams GS
Ann Intern Med; 1977 Mar; 86(3):257-60. PubMed ID: 842983
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II blockade in patients with essential hypertension.
MacGregor GA; Dawes PM
Aust N Z J Med; 1976 Aug; 6(3 Suppl):53-4. PubMed ID: 1071404
[TBL] [Abstract][Full Text] [Related]
18. The immediate pressor response to saralasin in man: a test of angiotensin II receptor vacancy.
Wallace JM; Case DB; Laragh JH; Keim HJ; Drayer JI; Sealey JE
Circ Res; 1979 Jan; 44(1):38-44. PubMed ID: 214254
[TBL] [Abstract][Full Text] [Related]
19. The effects of the angiotensin II antagonist saralasin on blood pressure and plasma aldosterone in man in relation to the prevailing plasma angiotensin II concentration.
Brown JJ; Brown WC; Fraser R; Lever AF; Morton JJ; Robertson JI; Rosei EA; Trust PM
Prog Biochem Pharmacol; 1976; 12():230-41. PubMed ID: 1019166
[TBL] [Abstract][Full Text] [Related]
20. Saralasin bolus test. Rapid screening procedure for renin-mediated hypertension.
Marks LS; Maxwell MH; Kaufman JJ
Lancet; 1975 Oct; 2(7939):784-7. PubMed ID: 78152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
